A limited epidemiological study of seropositive myasthenia gravis in tayside

Scottish Medical Journal

Volumn 47, Issue 6, 2002, Pages 132-135

  Farrugia, Maria Elena ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Acetylcholine receptor; Epidemiology; MuSK; Repetitive nerve stimulation; Seronegative myasthenia gravis; Seropositive myasthenia gravis; Single fibre EMG; Tensilon test

Indexed keywords

ACETYLCHOLINESTERASE; AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID; NICOTINIC RECEPTOR; PENICILLAMINE; PREDNISOLONE; PYRIDOSTIGMINE; RECEPTOR ANTIBODY; STEROID;

ACCURACY; ADULT; AGED; BULBAR PARALYSIS; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIAPHRAGM PARALYSIS; DRUG TOLERABILITY; ELECTROMYOGRAM; EPIDEMIOLOGICAL DATA; EXTRAOCULAR MUSCLE; FACE MUSCLE; FEMALE; HUMAN; INCIDENCE; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEPHROTOXICITY; NEUROMUSCULAR JUNCTION DISORDER; NEUROPATHOLOGY; OSTEOPOROSIS; PATIENT REFERRAL; PLASMAPHERESIS; RESPIRATORY FAILURE; REVIEW; SERODIAGNOSIS; SEX RATIO; THYMECTOMY; UNITED KINGDOM;

EID: 0036986328     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693300204700604     Document Type: Review

References (15)

1. Maher J, Grand Maison F, Nicolle MW, Strong MJ, Bolton CF. Diagnostic difficulties in myasthenia gravis. Clin Neurophysiol 2001; 112:1064-9.
2. Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 2001; 50:64-72.
3. Barton JJ, Fouladvand M. Ocular aspects of myasthenia gravis. Semin Neurol 2000; 20: 7-20.
4. Machens A, Loliger C, Pichlmeier U, Emskotter T, Busch C, Izbicki JR. Correlation of thymic pathology with HLA in myasthenia gravis. Clin Immunol 1999;91:296-301.
5. Pavesi G, Cattabeo L, Tinchelli S, Mancia D. Masseteric repetitive nerve stimulation in the diagnosis of myasthenia gravis. Clin Neurophysiol 2001; 112: 1064-9.
6. Gomez-Fernandez L, Vega-Treto H, Lestayo-Ofarril Z. [Single fibre electromyography in the diagnosis of myasthenia gravis]. Rev Neurol 2000; 30:609-13.
7. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature medicine 2001; 7:365-368.
8. Domanovits H, Wenger S, Schillinger M et al. [Edrophonium chloride (Tensilon) test: a safe method in diagnosing myasthenia gravis]. Wien Klin Wocheenschr 2000; 112:592-5.
9. Ing EB, Ing SY, Ing T, Ramocki JA. The complication rate of edrophonium testing for suspected myasthenia gravis. Can J Ophthalmol 2000; 35: 141-4.
10. Literature review of the usefulness of repetitive nerve stimulation and single fibre EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve 2001; 24:1239-1247.
11. Palace J, Newsom-Davis J, Lecky B. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia gravis study group. Neurology 1998; 50:1778-83.
12. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998; 65: 492-6.
13. Christensen PB, Jensen TS, Tsiropoulos I et al.. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 1993; 43; 1779-83.
14. Guidetti D, Sabadini R, Bondavalli M et al. Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 1998; 14:381-7.
15. Lavrnic D, Jarebinski M, Rakocevic - Stojanovic V et al. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand 1999; 100: 168-74.